Related Experiment Videos
CYP3A gene expression in human gut epithelium
J C Kolars1, K S Lown, P Schmiedlin-Ren
1Department of Internal Medicine, Veterans Administration Medical Center, Ann Arbor, MI 48109.
Pharmacogenetics
|October 1, 1994
Summary
Cytochrome P450 3A4 (CYP3A4) and CYP3A5 are present throughout the human digestive tract. Their varying expression may explain differences in drug metabolism across organs.
Area of Science:
- Pharmacology
- Gastroenterology
- Biochemistry
Background:
- Cytochrome P450 3A4 (CYP3A4) is a key enzyme in drug metabolism, primarily found in the liver and small intestine.
- Its presence in the digestive tract suggests a role in 'first pass' drug metabolism.
Purpose of the Study:
- To investigate the presence and distribution of CYP3A4 and related enzymes (CYP3A3, CYP3A5, CYP3A7) in various regions of the human digestive tract.
- To understand potential inter-organ variations in drug metabolism.
Main Methods:
- Histological examination of tissue sections and epithelial microsomes from a human organ donor using CYP3A-specific antibodies.
- Immunoblot analysis to identify specific CYP3A proteins.
- Polymerase chain reaction (PCR) and Northern blot analysis to detect CYP3A mRNA.
Main Results:
- CYP3A-related proteins were detected throughout the digestive tract, gastric parietal cells, hepatocytes, and pancreatic ductular cells.
- CYP3A4/CYP3A3 was predominant in the liver, jejunum, colon, and pancreas; CYP3A5 was dominant in the stomach.
- CYP3A4 and CYP3A5 mRNA were found in all digestive tract regions, but only CYP3A4 mRNA was detectable by Northern blot.
Conclusions:
- CYP3A4 and CYP3A5 are expressed throughout the human digestive tract.
- Differential expression of these enzymes across organs may contribute to variations in the metabolism of drugs processed by CYP3A.